Skip to main content
Signal8

GeoVax Labs, Inc. (GOVX) Form 8-K — Nov 19, 2026

$GOVXForm 8-KItems 5.02, 9.01Filed Nov 19, 2026, 5:23 PM ET0001437749-26-037764Original filing

GeoVax Labs disclosed that CFO Mark W. Reynolds resigned effective November 13, 2026, and that Chief Medical Officer Kelly T. McKee was terminated effective November 17, 2026. Reynolds had also served as the company's principal financial and accounting officer.

Key figures

Termination notice days
90
Interim ceo fee monthly usd
15000
Cfo consulting fee monthly usd
10000

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.